Development of monoclonal antibody-based immunoassays for quantification and rapid assessment of dihydroartemisinin contents in antimalarial drugs

Dihydroartemisinin (DHA) is one of the artemisinin derivatives widely used in artemisinin-based combination therapies (ACTs) for malaria treatment. The availability of a point-of-care device for estimation of DHA quantity would allow a quick quality assessment of the DHA-containing drugs. In this st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Pharm Biomed Anal
Autores principales: Ning, Xiangxue, Li, Weizhi, Wang, Mian, Guo, Suqin, Tan, Guiyu, Wang, Baomin, Cui, Liwang
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6363535/
https://ncbi.nlm.nih.gov/pubmed/29980021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2018.06.051
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares